Sri Annapurna (Ap) Drugs Private Limited, a active private limited company, was established on 03 April 2008 in Kamareddy, Andhra Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85100AP2008PTC058513. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹9.00 M and a paid-up capital of ₹9.00 M.
It upholds a compliant status. Its leadership includes Srinivas Bodige (Director), Annapurna Gajawada (Director), Ravikumar Gajawada (Director). Past directors included Ravinder Parsi, Bharathi Gajawada, Laxminarayana Gajawada. It holds ₹5.20 Cr open charges and ₹5.94 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No 5-3-652/A Vidya Nagar Colony, Kamareddy, Andhra Pradesh, 503111.
U85100AP2008PTC058513
058513
03 April 2008
₹9.00 M
₹9.00 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Sri Annapurna (Ap) Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivas Bodige | Director | 24 Dec 2013 | Current |
| Annapurna Gajawada | Director | 21 Jul 2011 | Current |
| Ravikumar Gajawada | Director | 24 Dec 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Mar 2010 | Past |
| Pramod Abcsdd | Additional Director | 10 Jan 2017 | Past |
| Pramod Abcsdd | Director | 21 Jul 2011 | Past |
| Pramod Abcsdd | Additional Director | 04 Nov 2008 | Past |
| Pramod Abcsdd | Additional Director | 22 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sri Annapurna (Ap) Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.23% decrease. The company also saw a substantial fall in profitability, with a 15.98% decrease in profit. The company's net worth moved up by a moderate rise of 2.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sri Annapurna (Ap) Drugs had a public holding of 39.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹52,000,000.00
₹59,400,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2016 | Axis Bank Limited | ₹5.20 Cr | Open |
| 05 Dec 2022 | Hdfc Bank Limited | ₹4.50 Cr | Satisfied |
| 13 Jun 2014 | Syndicate Bank | ₹9.50 M | Satisfied |
| 14 Feb 2013 | Andhra Bank | ₹4.90 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sri Annapurna (Ap) Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sri Annapurna (Ap) Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Annapurna (Ap) Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Axis Bank Limited of Rs. 52.00 M registered on 04 Feb 2016 with Charge ID 10625733 was modified on 21 Jul 2025. was documented.
Sri Annapurna (Ap) Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Sri Annapurna (Ap) Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was completed.
Progress on A charge registered on 05 Dec 2022 via Charge ID 100695119 with Hdfc Bank Limited was fully satisfied on 08 May 2023. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 45.00 M with Charge ID 100695119 was registered on 05 Dec 2022. was recorded as a recent event.
Progress on A charge registered on 13 Jun 2014 via Charge ID 10521281 with Syndicate Bank was fully satisfied on 16 Feb 2016. was documented.
The CIN of Sri Annapurna (Ap) Drugs Private Limited is U85100AP2008PTC058513.
Sri Annapurna (Ap) Drugs Private Limited is headquartered at H.No 5-3-652/A Vidya Nagar Colony, Kamareddy, Andhra Pradesh, 503111.
Sri Annapurna (Ap) Drugs Private Limited was incorporated on 03 April 2008.
The current directors of Sri Annapurna (Ap) Drugs Private Limited are
The primary industry of Sri Annapurna (Ap) Drugs Private Limited is Trade.
Sri Annapurna (Ap) Drugs Private Limited is unlisted.
The authorized capital of Sri Annapurna (Ap) Drugs Private Limited is ₹9.00 M, and the paid-up capital is ₹9.00 M.
The compliance status of Sri Annapurna (Ap) Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
_DRUGS_PRIVATE_LIMITED.webp)
Company Details
+91-XXXXXXXXXX